# Sugammadex Titration in Cardiac Surgery Patients

Study · id `cardio:ct-nct05246397` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05246397](<https://clinicaltrials.gov/study/NCT05246397>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05246397

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT05246397. Allocation not applicable; no masking; primary purpose other. Start 2022-02-01 (actual); primary completion 2022-11-10 (actual). Results posted on 2024-03-21.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Started: 2022-02-01 (actual) (ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Primary completion: 2022-11-10 (actual) (ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Completion: 2022-11-10 (actual) (ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Results first posted: 2024-03-21 (ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05246397, source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05246397-2024-03-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sugammadex Titration in Cardiac Surgery Patients
- Condition: Coronary Artery Disease
- Condition: Valvular Heart Disease
- Condition: Aorta Disease
- Condition: Heart Failure
- Intervention (Drug): Sugammadex administration
- Lead sponsor: University of Washington
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University of Washington (`cardio:org-university-of-washington`)

## Provenance

Content hash: fd530de2a80c7f2911a79b15089e5ab12f2164b955092e4a3da10f9f95e5e473
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
